Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023
24 Oktober 2023 - 10:22PM
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company
leveraging novel next-generation sequencing (NGS) and multiomics
technologies to empower researchers and clinicians, today announced
that it will report financial results for the third quarter 2023
after the market close on Tuesday, November 14, 2023. The company’s
management will discuss the results during a conference call
beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the
conference call may do so by dialing 1-888-506-0062 for domestic
callers or 1-973-528-0011 for international callers and using
conference ID 616134 approximately five minutes prior to the start
time. A live and archived webcast of the event will be available at
investor.singulargenomics.com, in the Presentations & Events
section.
About Singular Genomics Systems, Inc.Singular
Genomics is a life science technology company that develops
next-generation sequencing and multiomics technologies. The
commercially available G4 Sequencing Platform is a powerful, highly
versatile benchtop genomic sequencer designed to produce fast and
accurate results. In addition, Singular Genomics commenced
development of the PX system, which leverages Singular’s
proprietary sequencing technology, applying it as an in situ
readout to look at RNA and proteins in single cells and tissue.
Singular Genomics’ mission is to empower researchers and clinicians
to advance science and medicine. Visit www.singulargenomics.com for
more information.
Investor ContactMatt
Clawson949-370-8500ir@singulargenomics.com
Media ContactDan Budwick,
1AB973-271-6085dan@1abmedia.com
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
Von Jun 2023 bis Jun 2024